If you want to attend a Final Four hoops matchup, it'd help to have lots of money. And one way to make some loot might be to follow Paul Noglows' stock-investment advice. The director of research at Lazard Capital Markets named a quartet of companies that just might turn out to be wildcard winners.
Joining "Squawk on the Street," Noglows called solar-cell manufacturer Sunpower "more efficient" than its rivals -- and declares, "this isn't a fad -- this is for real." He sees the alternative-energy firm rising some 44%, with a price target of $60.
A more traditional buy would be Pozen. The researcher told CNBC's Erin Burnett that the pharmaceuticals company has a migraine drug due for FDA review in August -- which could create a "billion-dollar opportunity."